These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
889 related items for PubMed ID: 17636212
1. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY. Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [Abstract] [Full Text] [Related]
2. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D. Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [Abstract] [Full Text] [Related]
3. [Effect of small interference RNA on E6, E7 mRNA of human papillomavirus type-18 in cervical cancer cells]. Wang P, Cui ZM, Luo B, Lin P. Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):190-3. PubMed ID: 16640887 [Abstract] [Full Text] [Related]
4. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Jiang M, Milner J. Oncogene; 2002 Sep 05; 21(39):6041-8. PubMed ID: 12203116 [Abstract] [Full Text] [Related]
5. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA. Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, Ikeda Y, Kizaki M, Yoshinouchi M. Cancer Gene Ther; 2006 Mar 05; 13(3):234-41. PubMed ID: 16138119 [Abstract] [Full Text] [Related]
6. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Jonson AL, Rogers LM, Ramakrishnan S, Downs LS. Gynecol Oncol; 2008 Nov 05; 111(2):356-64. PubMed ID: 18755502 [Abstract] [Full Text] [Related]
7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB. Cancer Gene Ther; 1995 Mar 05; 2(1):19-32. PubMed ID: 7621252 [Abstract] [Full Text] [Related]
8. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D. Apoptosis; 2008 Feb 05; 13(2):273-81. PubMed ID: 18060502 [Abstract] [Full Text] [Related]
9. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs. Koivusalo R, Krausz E, Helenius H, Hietanen S. Mol Pharmacol; 2005 Aug 05; 68(2):372-82. PubMed ID: 15908516 [Abstract] [Full Text] [Related]
10. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D. Gynecol Oncol; 2007 Aug 05; 106(2):299-304. PubMed ID: 17586029 [Abstract] [Full Text] [Related]
11. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ. Clin Cancer Res; 2007 Jan 01; 13(1):132-8. PubMed ID: 17200347 [Abstract] [Full Text] [Related]
12. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer]. Peralta-Zaragoza O, Bermúdez-Morales VH, Madrid-Marina V. Rev Invest Clin; 2010 Jan 01; 62(1):63-80. PubMed ID: 20415061 [Abstract] [Full Text] [Related]
13. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells]. Sima N, Kong DB, Wang W, Lu YP, Wang SX, Ma D. Zhonghua Yi Xue Za Zhi; 2007 Jun 19; 87(23):1618-21. PubMed ID: 17803852 [Abstract] [Full Text] [Related]
14. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E, Jung Kim H, Jae Lee C, Tae Kang H, Seong Hwang E. Gynecol Oncol; 2004 Jul 19; 94(1):40-7. PubMed ID: 15262117 [Abstract] [Full Text] [Related]
15. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Putral LN, Bywater MJ, Gu W, Saunders NA, Gabrielli BG, Leggatt GR, McMillan NA. Mol Pharmacol; 2005 Nov 19; 68(5):1311-9. PubMed ID: 16120770 [Abstract] [Full Text] [Related]
16. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Peñalver M, Averette HE. Gynecol Oncol; 1997 Jan 19; 64(1):18-25. PubMed ID: 8995542 [Abstract] [Full Text] [Related]
17. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki]. Niu XY, Peng ZL, Wang H. Ai Zheng; 2004 Nov 19; 23(11):1257-62. PubMed ID: 15522169 [Abstract] [Full Text] [Related]
18. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES. Gynecol Oncol; 2001 Feb 19; 80(2):168-75. PubMed ID: 11161855 [Abstract] [Full Text] [Related]
19. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T, Sasaki C, Weinberger P, Psyrri A. J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448 [Abstract] [Full Text] [Related]
20. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells. Lee K, Lee AY, Kwon YK, Kwon H. Biochem Biophys Res Commun; 2011 Aug 26; 412(2):328-33. PubMed ID: 21821000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]